Humacyte (HUMA) PT Lowered to $1 at Piper Sandler as 'Symvess Sales Fall Short'
Tweet Send to a Friend
Piper Sandler analyst Allison M. Bratzel lowered the price target on Humacyte (NASDAQ: HUMA) to $1.00 (from $3.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
